To include your compound in the COVID-19 Resource Center, submit it here.

Cardene I: Phase IV data

The open-label, U.S. Phase IV CLUE trial in 226 patients admitted to the emergency room with 2

Read the full 177 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE